Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis.
Mallardo D, Giannarelli D, Vitale MG, Galati D, Trillò G, Esposito A, Isgrò MA, D'Angelo G, Festino L, Vanella V, Trojaniello C, White A, De Cristofaro T, Bailey M, Pignata S, Caracò C, Petrillo A, Muto P, Maiolino P, Budillon A, Warren S, Cavalcanti E, Ascierto PA.
Mallardo D, et al. Among authors: esposito a.
J Immunother Cancer. 2022 Nov;10(11):e005132. doi: 10.1136/jitc-2022-005132.
J Immunother Cancer. 2022.
PMID: 36424033
Free PMC article.